STunning in Acute Myocardial Infarction - BAS

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06562582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06562582
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06562582. Randomized; no masking; primary purpose treatment. Start 2025-01-06 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STunning in Acute Myocardial Infarction - BAS
Acronym
STAMI-BAS
Condition
Myocardial Infarct
Intervention (Drug)
Bisoprolol Oral Tablet
Intervention (Drug)
Ramipril Oral Product
Intervention (Drug)
Dapagliflozin Oral Product
Lead sponsor
Vastra Gotaland Region (class: other government)

Record details

Record id
cardio:ct-nct06562582
Content hash
87bd89d721db4492fb86111d0021e7d0e1c93fedbafe411bdccb1fe693413e68